A comprehensive monocentric ophthalmic study with Gaucher disease type 3 patients: vitreoretinal lesions, retinal atrophy and characterization of abnormal saccades

被引:0
|
作者
Susanne Hopf
Norbert Pfeiffer
Matthias Liesenfeld
Karl-Eugen Mengel
Julia B. Hennermann
Irene Schmidtmann
Susanne Pitz
机构
[1] University Medical Center Mainz,Department of Ophthalmology
[2] Clinic for Anaesthesia,Villa Metabolica, Center for Pediatric and Adolescent Medicine
[3] Surgical Intensive Care,Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI)
[4] Emergency Medicine and Pain Therapy,Orbital Center, Ophthalmic Clinic
[5] Klinikum Frankfurt Höchst,undefined
[6] University Medical Center Mainz,undefined
[7] University Medical Center Mainz,undefined
[8] Bürgerhospital Frankfurt,undefined
关键词
Saccadometry; Video-oculography; Saccades; Gaucher’s disease; Gaucher disease type III; Retina; Vitreous opacity; Ophthalmology; Neuro-ophthalmology; Lysosomal storage disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 23 条
  • [21] A PHASE3, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, MULTI CENTER STUDY (ENGAGE) TO INVESTIGATE THE EFFICACY AND SAFETY OF ELIGLUSTAT IN PATIENTS WITH GAUCHER DISEASE TYPE 1: 9 MONTH RESULTS
    Lukina, E.
    Dridi, M.
    Amato, D.
    Baris, H.
    Dasouki, M.
    Ghosn, M.
    Mehta, A.
    Packman, S.
    Pastores, G.
    Petakov, M.
    Assouline, S.
    Balwani, M.
    Danda, S.
    Hadjiev, E.
    Mistry, P.
    Ortega, A.
    Shankar, S.
    Solano, M.
    Marulkar, S.
    Peterschmitt, J.
    HAEMATOLOGICA, 2013, 98 : 405 - 406
  • [22] Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 3. Retinal vascular occlusion in patients with type 2 diabetes mellitus
    Bhattacharjee, Harsha
    Barman, Manabjyoti
    Misra, Divakant
    Multani, Prabhjot K.
    Dhar, Shriya
    Behera, Umesh C.
    Das, Taraprasad
    Gilbert, Clare
    Murthy, G. V. S.
    Rajalakshmi, R.
    Pant, Hira B.
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2020, 68 : S27 - S31
  • [23] A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in patients with Gaucher disease type 1 (ENGAGE): Results after 9 months of treatment
    Mistry, Pramod
    Lukina, Elena
    Ben Dridi, Marie-Francoise
    Amato, Dominick
    Baris, Hagit
    Dasouki, Majed
    Ghosn, Marwan
    Mehta, Atul
    Packman, Seymour
    Pastores, Gregory
    Petakov, Milan
    Peterschmitt, M. Judith
    MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : S66 - S67